Article
Effect of polymorphisms in XPD on clinical outcomes of platinum-based chemotherapy for Chinese non-small cell lung cancer patients.
PloS one - 1 Jan 2012
Wu Wenting, Li Huan, Wang Huibo, Zhao Xueying, Gao Zhiqiang, Qiao Rong, Zhang Wei, Qian Ji, Wang Jiucun, Chen Hongyan, Wei Qingyi, Han Baohui, Lu Daru
Abstract excerpt
PURPOSE: Xeroderma pigmentosum group D (XPD) codes for a DNA helicase involved in nucleotide excision repair that removes platinum-induced DNA damage. Genetic polymorphisms of XPD may affect DNA repair capacity and lead to individual differences in the outcome of patients after chemotherapy. This study aims to identify whether XPD polymorphisms affect clinical efficacy among advanced non-small cell lung cancer...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
